Detail
| LncRNA Name | NAMA |
| Synonyms | NAMA |
| Region | GRCh38_9:99355337-99377240 Sequence |
| Ensembl | ENSG00000271086 |
| RefSeq | NR_102270 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✔ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | papillary thyroid cancer |
| ICD-0-3 | M8260/3 |
| Methods | qPCR, RNAi, Western blot, Northern blot etc. |
| Sample | PTA tissues tissues, cell lines (NPA87, K1, K2 etc.) |
| Expression Pattern | down-regulated |
| Function Description | The downregulation of NAMA in PTCs with the BRAF*V600E mutation led us to test whether NAMA is regulated by the MAP kinase pathway. We suggest that NAMA is a noncoding RNA associated with growth arrest. |
| Pubmed ID | 17415708 |
| Year | 2007 |
| Title | Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest. |
| External Links |
| Links for NAMA | GenBank HGNC lncrnadb Noncode |
| Links for papillary thyroid cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.